Search results for esr2

327 hits were found for esr2

# Family MCID Name MIFTS Score
1
c OVR120 Ovarian Dysgenesis 8 19 33.331
2
P BRS047 Breast Cancer 97 21.969
3
P CLR023 Colorectal Cancer 100 19.308
4
END057 Endometrial Cancer 76 16.412
5
P OVR042 Ovarian Cancer 88 16.050
6
P LNG032 Lung Cancer 98 15.316
7
P INF032 Infertility 60 14.738
8
P PRS040 Prostate Cancer 95 14.112
9
P OST002 Osteoporosis 76 13.733
10
P END044 Endometriosis 62 13.544
11
P GST053 Gastric Cancer 82 12.626
12
P MLN007 Male Infertility 56 11.997
13
SMN007 Seminoma 42 11.350
14
GRM005 Germ Cell Cancer 46 11.308
15
LMY002 Leiomyoma 51 10.991
16
BRS099 Breast Ductal Carcinoma 61 10.963
17
BRS051 Breast Disease 58 10.727
18
END062 Endometrial Hyperplasia 47 10.650
19
P DBT009 Diabetes Mellitus 67 10.650
20
CLN015 Colon Adenocarcinoma 64 10.596
21
P SCH015 Schizophrenia 74 10.464
22
P SLV026 Salivary Gland Carcinoma 59 10.464
23
P HYP040 Hypospadias 51 10.354
24
P SCL018 Scoliosis 57 10.274
25
IDP070 Idiopathic Scoliosis 41 10.274
26
THY111 Thyroid Carcinoma, Familial Medullary 67 10.201
27
c SPR009 Sporadic Breast Cancer 42 10.138
28
P CRD246 Cardiovascular System Disease 55 9.574
29
P OVR046 Ovarian Cyst 43 9.496
30
P TST026 Testicular Germ Cell Cancer 42 9.387
31
c ATS007 Autism Spectrum Disorder 71 8.939
32
PRM013 Premature Menopause 57 8.916
33
P OVR049 Ovarian Disease 50 8.892
34
ADN027 Adenomyosis 59 8.838
35
P INT099 Intrahepatic Cholestasis of Pregnancy 61 8.807
36
P LNG064 Lung Cancer Susceptibility 3 69 8.772
37
DNT001 Dental Fluorosis 43 8.730
38
P EST001 Estrogen-Receptor Positive Breast Cancer 49 8.676
39
P ASP001 Asperger Syndrome 48 8.676
40
SRS001 Serous Cystadenocarcinoma 51 8.676
41
END041 Endometrial Adenocarcinoma 63 8.676
42
P PRG002 Progesterone-Receptor Positive Breast Cancer 33 8.544
43
DCT002 Ductal Carcinoma in Situ 58 8.544
44
PTT048 Pituitary Adenoma, Prolactin-Secreting 64 8.544
45
c HYP595 Hypertension, Essential 84 8.544
46
VGN023 Vaginitis 56 8.544
47
P DYS005 Dyslexia 40 8.544
48
OVR034 Ovarian Clear Cell Adenocarcinoma 40 8.544
49
END031 Endometrial Stromal Sarcoma 45 8.544
50
CYS014 Cystadenocarcinoma 51 8.544
51
LBL001 Lobular Neoplasia 54 8.544
52
TRN007 Transsexualism 38 8.544
53
GYN001 Gynecomastia 48 8.544
54
GND002 Gender Identity Disorder 40 8.544
55
UTR024 Uterine Carcinosarcoma 58 8.544
56
OVR012 Ovarian Serous Cystadenocarcinoma 55 8.544
57
END011 Endometriosis of Ovary 40 7.135
58
PRG014 Progesterone Resistance 42 7.047
59
P PLV020 Pelvic Organ Prolapse 57 6.305
60
CRY035 Cryptorchidism, Unilateral or Bilateral 57 6.173
61
UTR031 Uterine Benign Neoplasm 30 6.042
62
THR011 Thoracic Benign Neoplasm 31 6.042
63
VGN016 Vaginal Benign Neoplasm 24 6.042
64
BRS046 Breast Benign Neoplasm 30 6.042
65
P PRM051 Primary Pigmented Nodular Adrenocortical Disease 55 6.042
66
ATS009 Autosomal Genetic Disease 26 6.042
67
WHM001 Whim Syndrome 60 6.042
68
c VNM003 Van Maldergem Syndrome 1 50 6.042
69
ATS010 Autosomal Recessive Disease 42 6.042
70
RPR001 Reproductive Organ Benign Neoplasm 31 6.042
71
c AML044 Amelogenesis Imperfecta, Type Ig 54 6.042
72
ARM004 Aromatase Excess Syndrome 52 6.042
73
BNR001 Bone Remodeling Disease 29 6.042
74
BNR002 Bone Resorption Disease 47 6.042
75
TTH006 Tooth Disease 51 6.042
76
P AML002 Amelogenesis Imperfecta 56 6.042
77
TTH005 Teeth Hard Tissue Disease 27 6.042
78
NNM008 Nonmucinous Bronchioloalveolar Adenocarcinoma 21 6.042
79
BLD035 Bile Duct Cystadenoma 32 6.042
80
VGN015 Vaginal Adenoma 25 6.042
81
DSS008 Disease of Mental Health 74 6.042
82
VGN017 Vaginal Cancer 58 6.042
83
MTH009 Mouth Disease 57 6.042
84
TRN006 Transvestism 31 6.042
85
c 46X082 46,xy Sex Reversal 52 6.042
86
EST004 Estrogen Excess 37 6.042
87
PST029 Postmenopausal Atrophic Vaginitis 39 6.042
88
P STM003 Stomach Carcinoma in Situ 25 6.042
89
UTR054 Uterine Hypoplasia 21 6.042
90
ESP021 Esophageal Cancer 84 1.776
91
c BNM022 Bone Mineral Density Quantitative Trait Locus 8 45 1.650
92
P BNM029 Bone Mineral Density Quantitative Trait Locus 15 48 1.650
93
PLM173 Palmoplantar Hyperkeratosis with Squamous Cell Carcinoma of Skin and 46,xx Sex Reversal 34 1.495
94
SKN022 Skin Squamous Cell Carcinoma 53 1.495
95
PSD011 Pseudovascular Skin Squamous Cell Carcinoma 16 1.495
96
THY029 Thyroid Carcinoma 55 1.487
97
P PLY011 Polycystic Ovary Syndrome 57 1.439
98
P RHM011 Rheumatoid Arthritis 81 1.422
99
c MGR028 Migraine with or Without Aura 1 63 1.385
100
FML037 Female Breast Cancer 51 1.366
101
ALL014 Allergic Encephalomyelitis 34 1.260
102
ECT041 Ectodermal Dysplasia-Syndactyly Syndrome 2 35 1.231
103
INS024 Insulin-Like Growth Factor I 77 1.200
104
THY125 Thyroid Gland Medullary Carcinoma 48 1.193
105
P GRV001 Graves' Disease 54 1.184
106
P SCL057 Scoliosis, Isolated 1 40 1.167
107
PRS047 Prostatitis 57 1.158
108
PRS021 Prostatic Adenoma 43 1.132
109
PRS045 Prostatic Hypertrophy 53 1.132
110
ANR007 Anorexia Nervosa 59 1.094
111
P MGR003 Migraine with Aura 51 1.073
112
P DMN002 Dementia 65 1.073
113
c PRC016 Pre-Eclampsia 64 1.052
114
P MGR001 Migraine Without Aura 48 1.030
115
MLD018 Mild Cognitive Impairment 48 1.006
116
OST012 Osteoarthritis 77 1.006
117
EST007 Estrogen Resistance 41 0.980
118
OVR029 Ovarian Hyperstimulation Syndrome 63 0.980
119
HYP066 Hyperglycemia 60 0.980
120
AZS001 Azoospermia 45 0.980
121
P PRD008 Periodontitis 63 0.980
122
OVR094 Ovarian Epithelial Cancer 39 0.980
123
MND021 Mandibular Hypoplasia, Deafness, Progeroid Features, and Lipodystrophy Syndrome 65 0.952
124
ATM095 Autoimmune Disease 61 0.952
125
AMN001 Amenorrhea 53 0.952
126
STR067 Stroke, Ischemic 79 0.921
127
P MYC007 Myocardial Infarction 69 0.921
128
P HPT023 Hepatocellular Carcinoma 95 0.921
129
P MLT074 Multiple Endocrine Neoplasia 58 0.921
130
CRB039 Cerebrovascular Disease 65 0.921
131
c PRD040 Periodontitis, Chronic 52 0.885
132
AGN016 Aging 53 0.885
133
c SPR162 Spermatogenic Failure 50 42 0.885
134
HYP043 Hyperandrogenism 47 0.885
135
P AGG001 Aggressive Periodontitis 55 0.885
136
c THY109 Thyroid Cancer, Nonmedullary, 1 55 0.843
137
P LYN001 Lynch Syndrome 76 0.843
138
HRD224 Hereditary Nonpolyposis Colon Cancer 51 0.843
139
IMP005 Impotence 52 0.789
140
P HDC001 Headache 56 0.789
141
SQM013 Squamous Cell Carcinoma, Head and Neck 75 0.705
142
LNG039 Lung Squamous Cell Carcinoma 57 0.610
143
ESP027 Esophagus Squamous Cell Carcinoma 45 0.610
144
LNG012 Lung Occult Squamous Cell Carcinoma 20 0.610
145
LNG007 Lung Mixed Small Cell and Squamous Cell Carcinoma 20 0.610
146
P PNC035 Pancreatic Cancer 87 0.517
147
MYL005 Myelofibrosis 70 0.517
148
P LKM071 Leukemia, Chronic Lymphocytic 74 0.517
149
VNH007 Von Hippel-Lindau Syndrome 72 0.498
150
RNL114 Renal Cell Carcinoma, Nonpapillary 79 0.498
151
MLT003 Multilocular Clear Cell Renal Cell Carcinoma 33 0.498
152
CLR030 Clear Cell Renal Cell Carcinoma 53 0.498
153
MLT165 Multilocular Cystic Renal Neoplasm of Low Malignant Potential 28 0.498
154
LMY014 Leiomyoma, Uterine 55 0.492
155
MNT002 Mental Depression 56 0.474
156
ADN018 Adenoma 58 0.456
157
c GLL024 Gallbladder Disease 1 53 0.436
158
P MJR001 Major Depressive Disorder 68 0.436
159
LPD008 Lipid Metabolism Disorder 61 0.436
160
DPR016 Depression 64 0.436
161
INT323 Intraocular Pressure Quantitative Trait Locus 63 0.416
162
P OPN001 Open-Angle Glaucoma 55 0.416
163
c BDY007 Body Mass Index Quantitative Trait Locus 1 40 0.395
164
SQM006 Squamous Cell Carcinoma 59 0.372
165
P ADN016 Adenocarcinoma 63 0.372
166
c MSM022 Mismatch Repair Cancer Syndrome 1 69 0.352
167
c GLM043 Glioma Susceptibility 9 30 0.352
168
c GLM025 Glioma Susceptibility 2 30 0.352
169
c GLM047 Glioma Susceptibility 3 32 0.352
170
MNN043 Meningioma, Familial 79 0.352
171
P GLM040 Glioma Susceptibility 1 70 0.352
172
P OLG002 Oligodendroglioma 66 0.352
173
P LNG021 Lung Occult Small Cell Carcinoma 20 0.352
174
LNG019 Lung Combined Type Small Cell Carcinoma 34 0.352
175
LNG111 Lung Non-Squamous Non-Small Cell Carcinoma 56 0.352
176
GLM045 Glioma 62 0.352
177
P ALZ034 Alzheimer Disease 87 0.348
178
c SML038 Small Cell Cancer of the Lung 68 0.348
179
PRS129 Prostatic Hyperplasia, Benign 48 0.348
180
P GLL018 Gallbladder Cancer 59 0.348
181
P SCL048 Sclerosteosis 58 0.322
182
c SYS001 Systemic Lupus Erythematosus 85 0.322
183
c BDY005 Body Mass Index Quantitative Trait Locus 9 47 0.322
184
c BDY006 Body Mass Index Quantitative Trait Locus 8 43 0.322
185
c BNM018 Bone Mineral Density Quantitative Trait Locus 3 33 0.322
186
c BDY010 Body Mass Index Quantitative Trait Locus 4 46 0.322
187
c BDY020 Body Mass Index Quantitative Trait Locus 19 51 0.322
188
c BDY011 Body Mass Index Quantitative Trait Locus 10 45 0.322
189
c BDY012 Body Mass Index Quantitative Trait Locus 7 43 0.322
190
c BDY019 Body Mass Index Quantitative Trait Locus 18 46 0.322
191
c BDY015 Body Mass Index Quantitative Trait Locus 12 46 0.322
192
c BDY017 Body Mass Index Quantitative Trait Locus 14 45 0.322
193
ACR007 Acromegaly 70 0.322
194
P PTT006 Pituitary Adenoma 55 0.322
195
P ART022 Arthritis 70 0.322
196
P LPS004 Lupus Erythematosus 61 0.322
197
c GLC092 Glaucoma, Primary Open Angle 60 0.294
198
HRW001 Hair Whorl 35 0.294
199
c DNT047 Dentinogenesis Imperfecta Type 2 35 0.294
200
ART140 Arteries, Anomalies of 52 0.263
201
P RTN024 Retinoblastoma 72 0.263
202
P BDY004 Body Mass Index Quantitative Trait Locus 11 82 0.263
203
LPP008 Lipoprotein Quantitative Trait Locus 65 0.263
204
HLX001 Helix Syndrome 47 0.263
205
P ZNC008 Zinc Finger Protein 1 22 0.263
206
HSH003 Hashimoto Thyroiditis 60 0.263
207
LYM040 Lymphoblastic Lymphoma 53 0.263
208
P RCT021 Rectum Cancer 54 0.263
209
P BNG032 Benign Mesothelioma 53 0.263
210
CHL068 Cholestasis 61 0.263
211
MDD011 Mood Disorder 61 0.263
212
P BCL017 B-Cell Lymphoma 57 0.263
213
P NRV007 Nervous System Disease 65 0.263
214
VSC002 Vascular Dementia 59 0.263
215
48X005 48,xyyy 39 0.263
216
P THY032 Thyroiditis 56 0.263
217
PRC049 Precursor T-Cell Acute Lymphoblastic Leukemia 44 0.263
218
TRD008 Triiodothyronine Receptor Auxiliary Protein 33 0.228
219
DWN001 Down Syndrome 70 0.228
220
P MDL005 Medulloblastoma 75 0.228
221
c HPT073 Hepatitis C Virus 70 0.228
222
MMM006 Mammographic Density 39 0.228
223
TTH032 Tooth Size 35 0.228
224
c MST023 Mesothelioma, Malignant 56 0.228
225
c LNG109 Lung Cancer Susceptibility 1 26 0.228
226
P ESP035 Esophagitis, Eosinophilic, 1 57 0.228
227
RPD005 Rapidly Involuting Congenital Hemangioma 48 0.228
228
CLR108 Colorectal Adenoma 63 0.228
229
LVR012 Liver Cirrhosis 62 0.228
230
ISC004 Ischemia 61 0.228
231
c HPT001 Hepatitis C 61 0.228
232
P ESP024 Esophagitis 60 0.228
233
MYF001 Myofibroma 42 0.228
234
TST015 Testicular Disease 42 0.228
235
PRM236 Primary Biliary Cholangitis 62 0.228
236
ETN001 Eating Disorder 59 0.228
237
MLG079 Malignant Pleural Mesothelioma 42 0.228
238
P PRC019 Precocious Puberty 48 0.228
239
SXL003 Sexual Disorder 49 0.186
240
ECT026 Ectopic Pregnancy 47 0.186
241
P ATS364 Autism 72 0.186
242
OBS002 Obsessive-Compulsive Disorder 67 0.186
243
c PLM164 Pulmonary Hypertension, Primary, 1 75 0.186
244
P BLD134 Bladder Cancer 79 0.186
245
ANX010 Anxiety 70 0.186
246
HYP025 Hyperphosphatemia 47 0.186
247
P TST021 Testicular Germ Cell Tumor 61 0.186
248
P AST005 Asthma 75 0.186
249
c PCH010 Pachyonychia Congenita 3 43 0.186
250
KGM001 Kagami-Ogata Syndrome 54 0.186
251
P HYP069 Hyperparathyroidism 62 0.186
252
GLB002 Glioblastoma 67 0.186
253
P VSC007 Vascular Disease 62 0.186
254
OVR105 Ovarian Serous Carcinoma 37 0.186
255
P BLD062 Bile Duct Cancer 69 0.186
256
SVR004 Severe Combined Immunodeficiency 70 0.186
257
P EPL164 Epilepsy 70 0.186
258
SVR001 Severe Acute Respiratory Syndrome 68 0.186
259
c PRM005 Primary Hyperparathyroidism 59 0.186
260
PRT037 Pertussis 49 0.186
261
PRT029 Parathyroid Adenoma 51 0.186
262
BLR013 Biliary Tract Cancer 43 0.186
263
GRM010 Germ Cells Tumors 33 0.186
264
PTR034 Paternal Uniparental Disomy 20 0.186
265
c UNP011 Uniparental Disomy of Chromosome 14 15 0.186
266
CLT003 Colitis 63 0.132
267
ALP042 Alpha/beta T-Cell Lymphopenia with Gamma/delta T-Cell Expansion, Severe Cytomegalovirus Infection, and Autoimmunity 65 0.132
268
P LYM118 Lymphoma 66 0.132
269
ATH013 Atherosclerosis Susceptibility 63 0.132
270
c FBR046 Fibrosis of Extraocular Muscles, Congenital, 1 58 0.132
271
c NPH055 Nephrotic Syndrome, Type 1 52 0.132
272
c ART138 Aortic Aneurysm, Familial Abdominal, 1 60 0.132
273
P MLT020 Multiple Sclerosis 79 0.132
274
c PRM032 Primary Congenital Glaucoma 40 0.132
275
PLM129 Pulmonary Disease, Chronic Obstructive 74 0.132
276
PRK066 Parkinsonism with Spasticity, X-Linked 26 0.132
277
P SPR119 Spermatogenic Failure, X-Linked, 1 36 0.132
278
c 46X049 46,xy Sex Reversal 2 51 0.132
279
c THR092 Thrombophilia Due to Thrombin Defect 74 0.132
280
c FNC028 Fanconi Anemia, Complementation Group L 46 0.132
281
KWS002 Kawasaki Disease 65 0.132
282
c ATR087 Atrial Standstill 1 74 0.132
283
BRK010 Burkitt Lymphoma 65 0.132
284
c NPH049 Nephrotic Syndrome, Type 2 49 0.132
285
c WLF013 Wolfram Syndrome 1 60 0.132
286
MNT001 Mantle Cell Lymphoma 65 0.132
287
P PRK039 Parkinsonism 55 0.132
288
THY121 Thyroid Gland Anaplastic Carcinoma 66 0.132
289
LWG006 Low Grade Glioma 41 0.132
290
HYP060 Hyperinsulinism 53 0.132
291
PST028 Post-Traumatic Stress Disorder 58 0.132
292
HYP080 Hypogonadism 49 0.132
293
VCC001 Vaccinia 49 0.132
294
P THR015 Thrombophilia 51 0.132
295
c BSL007 Basal Cell Carcinoma 67 0.132
296
P HYP730 Hypogonadotropic Hypogonadism 57 0.132
297
P ECL001 Eclampsia 52 0.132
298
P LVR013 Liver Disease 68 0.132
299
PLC005 Placental Insufficiency 55 0.132
300
P PLM036 Pulmonary Fibrosis 65 0.132
301
ART016 Aortic Aneurysm 68 0.132
302
TST014 Testicular Cancer 51 0.132
303
P HYP061 Hypertrophic Cardiomyopathy 68 0.132
304
GLC003 Glucose Intolerance 53 0.132
305
PRT013 Portal Hypertension 59 0.132
306
P UVT001 Uveitis 57 0.132
307
BNG018 Benign Paroxysmal Positional Nystagmus 40 0.132
308
P GND004 Gonadal Dysgenesis 46 0.132
309
P MLN008 Melanoma 75 0.132
310
ACT084 Acute Stress Disorder 53 0.132
311
PNC041 Pancreatic Ductal Adenocarcinoma 51 0.132
312
OVR059 Ovary Adenocarcinoma 49 0.132
313
SKN016 Skin Disease 63 0.132
314
SKN019 Skin Melanoma 70 0.132
315
HPT009 Hepatopulmonary Syndrome 48 0.132
316
P INF038 Influenza 68 0.132
317
CYT002 Cytokine Deficiency 43 0.132
318
PST021 Postpartum Depression 50 0.132
319
PTT037 Pituitary Tumors 44 0.132
320
ANR040 Aneurysm 60 0.132
322
HYD005 Hydrocele 46 0.132
323
P ALP008 Alopecia 53 0.132
324
P ALP009 Alopecia Areata 59 0.132
325
MCR225 Macrophage Activation Syndrome 45 0.132
326
SPS057 Spasticity 43 0.132
327
PST092 Posttransplant Acute Limbic Encephalitis 29 0.132
Content
Loading form....